Echo Street Capital Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-11,966
Closed -$2.87M 537
2023
Q2
$2.87M Sell
11,966
-178,807
-94% -$37.1M 0.02% 88
2023
Q1
$35.9M Buy
190,773
+19,068
+11% +$3.94M 0.32% 64
2022
Q4
$36.5M Sell
171,705
-479,856
-74% -$95.9M 0.35% 67
2022
Q3
$102M Buy
651,561
+1,128
+0.2% +$180K 0.98% 49
2022
Q2
$97.3M Sell
650,433
-44,903
-6% -$6.5M 0.88% 54
2022
Q1
$114M Buy
695,336
+108,133
+18% +$17.8M 0.82% 63
2021
Q4
$128M Sell
587,203
-45,879
-7% -$9.61M 0.86% 49
2021
Q3
$120M Buy
633,082
+172,558
+37% +$31.5M 0.84% 54
2021
Q2
$81.3M Buy
460,524
+249,531
+118% +$43.1M 0.63% 81
2021
Q1
$34.6M Buy
+210,993
New +$32.3M 0.31% 89

Other funds holding MEDP

Echo Street Capital Management's MEDP Position: Q3 2023 in Review

Echo Street Capital Management sold out of Medpace (MEDP) in Q3 2023, closing a stake of 11,966 shares — an estimated $2.87M sold.

Echo Street Capital Management first reported a position in MEDP in Q1 2021 and held it in 10 quarters. The position peaked at $128M in Q4 2021. 488 funds tracked by Wall St. Rank hold MEDP as of Q3 2023.

  • Echo Street Capital Management reported no remaining Medpace position as of Q3 2023 after selling out during the quarter.
  • Echo Street Capital Management sold 11,966 Medpace shares in Q3 2023, an estimated $2.87M.
  • Echo Street Capital Management first reported a position in Medpace in Q1 2021 and held it in 10 quarters.
  • Echo Street Capital Management's Medpace position peaked at $128M in Q4 2021.
  • 488 funds tracked by Wall St. Rank held Medpace as of Q3 2023.

Based on Echo Street Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.